Spain / 5 Key Industry Trends 2021
According to recent IQVIA and industry association reports, the Spanish pharma market, valued at EUR 21.6 billion per year, continues to grow at a relatively slow pace. Other key trends…
Catalonia / 5 Things to Know
A rundown of five things to know about the healthcare and life sciences industry in Catalonia. Nestled in Northeastern Spain and bordering France, Catalonia’s capital and largest city is Barcelona.…
Spain / Funneling EU Funds into “Historic” PPPs
Aiming to leverage European Union funds to reindustrialise its economy, the Spanish government has approved a public-private collaboration instrument to transform its health sector. The project looks to position Spain…
Spain / Sanifit Snapped Up by Vifor; Rovi Reaps Rewards from Moderna Partnership; New Milestone for Hipra’s COVID Vaccine
The latest from Spanish pharma, including Rovi’s better-than-expected 2021 results thanks to its Moderna partnership, the approval of Hipra’s COVID-19 IIb clinical trials, Sanifit Therapeutics’ acquisition by Vifor Pharma, and…
Global / Agility, Responsiveness, & Resilience: Five Takeaways from the 44th World Hospital Congress
Walt Vernon is CEO of US-based healthcare facilities consulting firm, Mazzetti, and non-profit, Sextant. He is on the Board of the FGI and served on NFPA 99 ELS, NFPA 70…
Spain / Entering the COVID-19 Vaccine Race Through Animal Health Champion
The Spanish pharma industry has entered the race to develop COVID-19 vaccines through an unexpected contender: an animal health company. HIPRA, headquartered in Catalonia, has received approval to begin human…
Spain / Grifols Invests in Nigerian Manufacturing; Almirall Nabs EMA Approval for AK Treatment; Zendal TB Vaccine Candidate Trials
The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP protection for medical advancements, Grifols’ expansion in Africa through a manufacturing plant in…
Spain / Market Growth; Esteve’s US Expansion; PTS Acquisition
The latest from Spanish pharma, including the acquisition of PTS by a private equity group for its nanoparticle drug delivery technologies; the agreement between Esteve and Kowa to license an…
Spain / Grifols looks to Egypt; New Leadership Generation at Almirall; Ferrer’s EIB Loan; Esteve’s European Expansion
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being produced in the country, Grifols’ Egyptian entry, a new generation of leadership at…
Spain / Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19 vaccine trial, the latest developments at Spanish firm PharmaMar which hopes its Aplidin can be used as a…
COVID-19 / Spain’s PharmaMar to Begin Trials for Aplidin
PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have soared on the news. PharmaMar is joining…
Report / New Spain Pharma Report September 2019 Out Now
Building on the topics covered in our March 2019 report, the latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences…